Rhodes Melissa
Reporting owner on Forms 3, 4 and 5, CIK 2127594.
Rhodes Melissa reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AVLN · Avalyn Pharma Inc.CIK 1540171 | officer (Chief Operating Officer) | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | M exercised | +13,300 | $4.62 | 13,300 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | S sold | -10,875 | $27.7918 | 2,425 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | S sold | -2,025 | $28.2069 | 400 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | S sold | -400 | $29.2286 | 0 | Form 4 |
| AVLN · Avalyn Pharma Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | M exercised | -13,300 | $0 | 170,638 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-468542 | Avalyn Pharma Inc. | 2026-11-19 |